Davis Krista 4

What Happened

Krista Davis, SVP and Chief HR Officer of ANI Pharmaceuticals, had 3,017 shares withheld on February 11, 2026 to satisfy tax withholding obligations related to the vesting of performance stock units. The shares were valued at $76.25 each, for a total value of approximately $230,046. The transaction is reported as a disposal (code F) because shares were surrendered to cover taxes, not sold on the open market.

Key Details

• Transaction date: 2026-02-11; Filing date: 2026-02-13 (appears timely).
• Price per share: $76.25; Shares withheld/disposed: 3,017; Total value ≈ $230,046.
• Shares owned after transaction: Not specified in the provided excerpt — see the Form 4 for post-transaction holdings.
• Footnote: Withholding was done to cover taxes on the vesting of 8,104 performance stock units granted April 6, 2023; the withholding is exempt under Rule 16b-3 (footnote F1).
• Transaction code: F (payment of exercise price or tax liability via share withholding).

Context

This was a routine tax-withholding action tied to vested performance stock units, not an open-market sale or new purchase. Such withholdings are common and generally do not signal the insider’s market view.